Clinical News

BBC Health 30 Jul 2025

Doctors’ union agrees to resume talks with Streeting

But the health secretary says he will not negotiate on pay, adding that the union has lost goodwill with their…

Read more →

BBC Health 30 Jul 2025

The doctor strike has ended – what comes next?

With doctors returning to work after five-day walkout, is there an opportunity for talks to re-start?

Read more →

BBC Health 26 Jul 2025

Sleep, exercise, hydrate – do we really need to stick to recommended daily doses?

As a study casts doubt on the daily steps maxim, we take a look at some other health benchmarks we’re…

Read more →

⚠️ Safety Alert

MHRA 07 Jul 2025

Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults

There is a small increase in the risk of Guillain-Barré syndrome following vaccination with Abrysvo (Pfizer respiratory syncytial virus (RSV)…

Read more →

⚠️ Safety Alert

MHRA 10 Jun 2025

Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): updated safety and educational materials to support patient discussion on reproductive risks

Updated safety and educational materials are now available to support the implementation of the regulatory measures announced in the November…

Read more →

⚠️ Safety Alert

MHRA 15 May 2025

Thiopurines and intrahepatic cholestasis of pregnancy

Intrahepatic cholestasis of pregnancy (ICP) has been rarely reported in patients treated with azathioprine products and is believed to be…

Read more →

⚠️ Safety Alert

MHRA 07 May 2025

Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects

Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people…

Read more →

⚠️ Safety Alert

MHRA 24 Apr 2025

Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines

Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of…

Read more →

⚠️ Safety Alert

MHRA 10 Apr 2025

Fezolinetant▼(Veoza): risk of liver injury; new recommendations to minimise risk

Fezolinetant treatment is associated with a risk of drug induced liver injury. New recommendations have been introduced to minimise this…

Read more →

⚠️ Safety Alert

MHRA 12 Mar 2025

Prolonged-release opioids: Removal of indication for relief of post-operative pain

The indication for the treatment of post-operative pain has been removed from the licences of all prolonged release opioids due…

Read more →